{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:56:01Z","timestamp":1784937361055,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nephropathy associated metabolic disorder induces high incidence of fragility fracture in end-stage renal disease (ESRD) patients. As the risk factors and prognosis of fragility fracture in ESRD patients are unclear, more research is needed. This study aimed to evaluate various risk factors for ESRD-related fragility fractures, explore factors affecting the prognosis of patients with such fractures, and provide information for prevention and treatment of renal osteopathy to improve the prognosis of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective case-control study, the case notes of 521 ESRD patients who received maintenance dialysis for at least 3\u2009months were examined. Finally, 44 patients diagnosed with fragility fractures were assigned to the fragility fracture (FF) group and 192 patients were included in the control group (CG). Demographic information, underlying diseases, nutritional, bone metabolism, and renal function parameters, along with the number and causes of any deaths, were recorded for multiple statistical analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The FF group had increased incidences of essential hypertension and diabetes mellitus and higher serum calcium, corrected calcium, alkaline phosphatase, and hemoglobin levels. Immunoreactive parathyroid hormone (iPTH), total cholesterol (TC), and low density lipoprotein (LDL) levels were higher in the CG. Multivariate Cox regression analysis revealed that fragility fracture was an independent risk factor for all-cause mortality in ESRD patients (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; .001, RR: 4.877, 95% CI: 2.367\u201310.013).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Essential hypertension and diabetes, high serum calcium and alkaline phosphatase levels, and reduced iPTH levels were risk factors for fragility fracture in ESRD patients. Maintaining iPTH and serum TC levels may protect against fragility fractures in them. Fragility fractures may yield poor prognosis and shorter lifespan. The presence of fragility fracture was an independent predictor of all-cause death in ESRD patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-02224-7","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T08:28:51Z","timestamp":1610353731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures"],"prefix":"10.1186","volume":"22","author":[{"given":"Lihua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuantao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-0446","authenticated-orcid":false,"given":"Zhengxiao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"2224_CR1","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD\u2013MBD). Kidney Int. 2009;76:S1-S130."},{"key":"2224_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007618","volume":"96","author":"LW Hung","year":"2017","unstructured":"Hung LW, Hwang YT, Huang GS, Liang CC, Lin J. The influence of renal dialysis and hip fracture sites on the 10-year mortality of elderly hip fracture patients: a nationwide population-based observational study. Medicine. 2017;96:e7618.","journal-title":"Medicine"},{"key":"2224_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4103\/1319-2442.206439","volume":"28","author":"MS Najar","year":"2017","unstructured":"Najar MS, Mir MM, Muzamil M. Prevalence of osteoporosis in patients with chronic kidney disease (stages 3-5) in comparison with age- and sex-matched controls: a study from Kashmir Valley tertiary care Center. Saudi J Kidney Dis Transpl. 2017;28:538\u201344.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2224_CR4","doi-asserted-by":"crossref","unstructured":"Wang AY, Akizawa T, Bavanandan S, et al. 2017 kidney disease: improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update implementation: Asia summit conference report. Kidney Int Rep. 2019;4:1523\u201337.","DOI":"10.1016\/j.ekir.2019.09.007"},{"key":"2224_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A, et al. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol. 2006;21:151\u20139.","journal-title":"Pediatr Nephrol"},{"key":"2224_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2458-8-117","volume":"8","author":"QL Zhang","year":"2008","unstructured":"Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117.","journal-title":"BMC Public Health"},{"key":"2224_CR7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/ki.2013.254","volume":"84","author":"RN Moorthi","year":"2013","unstructured":"Moorthi RN, Moe SM. Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney Int. 2013;84:886\u201394.","journal-title":"Kidney Int"},{"key":"2224_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jbm4.10117","volume":"2","author":"MJ Damasiewicz","year":"2018","unstructured":"Damasiewicz MJ, Nickolas TL. Rethinking bone disease in kidney disease. JBMR plus. 2018;2:309\u201322.","journal-title":"JBMR plus"},{"key":"2224_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000057611","volume":"91","author":"G Coen","year":"2002","unstructured":"Coen G, Ballanti P, Bonucci E, et al. Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH. Nephron. 2002;91:103\u201311.","journal-title":"Nephron"},{"key":"2224_CR10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/ndt\/gfn678","volume":"24","author":"D Nitsch","year":"2009","unstructured":"Nitsch D, Mylne A, Roderick PJ, Smeeth L, Hubbard R, Fletcher A. Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant. 2009;24:1539\u201344.","journal-title":"Nephrol Dial Transplant"},{"key":"2224_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5414\/CNP67201","volume":"67","author":"GT Schumock","year":"2007","unstructured":"Schumock GT, Sprague SM. Clinical and economic burden of fractures in patients with renal osteodystrophy. Clin Nephrol. 2007;67:201\u20138.","journal-title":"Clin Nephrol"},{"key":"2224_CR12","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1185\/030079907X199790","volume":"23","author":"QV Doan","year":"2007","unstructured":"Doan QV, Gleeson M, Kim J, Borker R, Griffiths R, Dubois RW. Economic burden of cardiovascular events and fractures among patients with end-stage renal disease. Curr Med Res Opin. 2007;23:1561\u20139.","journal-title":"Curr Med Res Opin"},{"key":"2224_CR13","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ejim.2014.10.017","volume":"25","author":"CH Tseng","year":"2014","unstructured":"Tseng CH, Huang WS, Li TC, Chen HJ, Muo CH, Kao CH. Increased risk of end-stage renal disease among hip fracture patients. Eur J intern Med. 2014;25:956\u201361.","journal-title":"Eur J intern Med"},{"key":"2224_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00198-013-2457-8","volume":"25","author":"S Yang","year":"2014","unstructured":"Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen TV. Association between hypertension and fragility fracture: a longitudinal study. Osteoporo Int. 2014;25:97\u2013103.","journal-title":"Osteoporo Int"},{"key":"2224_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00198-007-0386-0","volume":"18","author":"U Sennerby","year":"2007","unstructured":"Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaelsson K. Cardiovascular diseases and future risk of hip fracture in women. Osteoporo Int. 2007;18:1355\u201362.","journal-title":"Osteoporo Int"},{"key":"2224_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00223-008-9198-2","volume":"84","author":"P Vestergaard","year":"2009","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for fractures. Calcif Tissue Int. 2009;84:103\u201311.","journal-title":"Calcif Tissue Int"},{"key":"2224_CR17","doi-asserted-by":"publisher","first-page":"E183","DOI":"10.5489\/cuaj.2695","volume":"9","author":"MA Rull","year":"2015","unstructured":"Rull MA, Cano-Garcia Mdel C, Arrabal-Martin M, Arrabal-Polo MA. The importance of urinary calcium in postmenopausal women with osteoporotic fracture. Can Urol Assoc. 2015;9:E183\u20136.","journal-title":"Can Urol Assoc"},{"key":"2224_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ecl.2013.09.004","volume":"43","author":"S Kurra","year":"2014","unstructured":"Kurra S, Fink DA, Siris ES. Osteoporosis-associated fracture and diabetes. Endocrinol Metab Clin N Am. 2014;43:233\u201343.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2224_CR19","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1210\/jc.2017-00042","volume":"102","author":"SA Paschou","year":"2017","unstructured":"Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 diabetes and osteoporosis: a guide to optimal management. J Clin Endocrinol Metab. 2017;102:3621\u201334.","journal-title":"J Clin Endocrinol Metab"},{"key":"2224_CR20","first-page":"697","volume":"155","author":"O Tell-Lebanon","year":"2016","unstructured":"Tell-Lebanon O, Rotman-Pikielny P. Osteoporosis and diabetes - in which way are they related? Harefuah. 2016;155:697\u2013701.","journal-title":"Harefuah"},{"key":"2224_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00296-008-0784-4","volume":"29","author":"F Sivas","year":"2009","unstructured":"Sivas F, Alemdaroglu E, Elverici E, Kulug T, Ozoran K. Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. Rheumatol Int. 2009;29:885\u201390.","journal-title":"Rheumatol Int"},{"key":"2224_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1507\/endocrj.49.211","volume":"49","author":"T Yamaguchi","year":"2002","unstructured":"Yamaguchi T, Sugimoto T, Yano S, et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr J. 2002;49:211\u20137.","journal-title":"Endocr J"},{"key":"2224_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fendo.2018.00030","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Dai J, Zhong W, Hu C, Lu S, Chai Y. Association between serum cholesterol level and osteoporotic fractures. Front Endocrinol. 2018;9:30.","journal-title":"Front Endocrinol"},{"key":"2224_CR24","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00198-010-1367-2","volume":"22","author":"P Trimpou","year":"2011","unstructured":"Trimpou P, Oden A, Simonsson T, Wilhelmsen L, Landin-Wilhelmsen K. High serum total cholesterol is a long-term cause of osteoporotic fracture. Osteoporo Int. 2011;22:1615\u201320.","journal-title":"Osteoporo Int"},{"key":"2224_CR25","doi-asserted-by":"crossref","unstructured":"Matias PJ, Laranjinha I, Azevedo A, et al. Bone fracture risk factors in prevalent hemodialysis patients. J Bone Miner Metab. 2019.","DOI":"10.1007\/s00774-019-01041-9"},{"key":"2224_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","volume":"33","author":"K Atsumi","year":"1999","unstructured":"Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis. 1999;33:287\u201393.","journal-title":"Am J Kidney Dis"},{"key":"2224_CR27","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","volume":"29","author":"Y Maruyama","year":"2014","unstructured":"Maruyama Y, Taniguchi M, Kazama JJ, et al. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol Dial Transplant. 2014;29:1532\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"2224_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2215\/CJN.06091108","volume":"4","author":"R Shantouf","year":"2009","unstructured":"Shantouf R, Kovesdy CP, Kim Y, et al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1106\u201314.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2224_CR29","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.jacc.2015.09.087","volume":"66","author":"GR Ten Kate","year":"2015","unstructured":"Ten Kate GR, Bos S, Dedic A, et al. Increased aortic valve calcification in familial hypercholesterolemia: prevalence, extent, and associated risk factors. J Am Coll Cardiol. 2015;66:2687\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"2224_CR30","doi-asserted-by":"crossref","unstructured":"Groff H, Kheir MM, George J, Azboy I, Higuera CA, Parvizi J. Causes of in-hospital mortality after hip fractures in the elderly. Hip Int. 2019;1120700019835160.","DOI":"10.1177\/1120700019835160"},{"key":"2224_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.otsr.2016.05.016","volume":"102","author":"AC Dodd","year":"2016","unstructured":"Dodd AC, Bulka C, Jahangir A, Mir HR, Obremskey WT, Sethi MK. Predictors of 30-day mortality following hip\/pelvis fractures. Orthop Traumatol Surg Res. 2016;102:707\u201310.","journal-title":"Orthop Traumatol Surg Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02224-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-02224-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02224-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T08:49:21Z","timestamp":1610354961000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02224-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02224-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-101968\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"3 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the institutional review board of Central South University. The retrospective study was based on non-interventional data analysis, therefore the written informed consent was waived by the institutional review board according to Technical Guidelines for Clinical Trials of Diagnostic Reagents in Vitro (the attachment of No. 16 announcement in 2014) issued by the China Food and Drug Administration.The access to the the clinic data bank in The Second Xiangya Hospital of Central South University requires the application for scientific research purpose, which is approved by the institutional review board of Central South University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No competing interests are declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}